Payment overview · 2025
General Payments
$346.83
3 reported records · 3 companies
Healthcare provider profile · identity verified
Michael N Harris, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BEND, OR · NPI 1023047503
Verified facts
What the public records show
CMS Open Payments records show Michael N Harris, M.D. received $346.83 in general payments during 2025 across 3 reported records.
Amgen Inc. accounted for 42.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $147.06 | 42.4% | 1 | 2025 |
| Ionis Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $107.28 | 30.9% | 1 | 2025 |
| Regeneron Healthcare Solutions, Inc. | Unresolved — no canonical attribution shown | $92.49 | 26.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $346.83 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EVKEEZA Normalized: evkeeza |
Biological | Regeneron Healthcare Solutions, Inc. | $92.49 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 1324 | 416 |
| Ezetimibe | Ezetimibe | 1046 | 338 |
| Atorvastatin Calcium | Atorvastatin Calcium | 963 | 316 |
| Levothyroxine Sodium | Levothyroxine Sodium | 685 | 190 |
| Telmisartan | Telmisartan | 484 | 136 |
| Metformin Hcl Er | Metformin Hcl | 433 | 122 |
| Hydrochlorothiazide | Hydrochlorothiazide | 373 | 118 |
| Amlodipine Besylate | Amlodipine Besylate | 366 | 126 |
| Trazodone Hcl | Trazodone Hcl | 305 | 100 |
| Omeprazole | Omeprazole | 254 | 95 |
| Lisinopril | Lisinopril | 249 | 89 |
| Tamsulosin Hcl | Tamsulosin Hcl | 223 | 71 |
| Losartan Potassium | Losartan Potassium | 220 | 79 |
| Pantoprazole Sodium | Pantoprazole Sodium | 215 | 75 |
| Candesartan Cilexetil | Candesartan Cilexetil | 214 | 57 |
| Eliquis | Apixaban | 213 | 63 |
| Gabapentin | Gabapentin | 211 | 75 |
| Metoprolol Succinate | Metoprolol Succinate | 211 | 71 |
| Alendronate Sodium | Alendronate Sodium | 174 | 54 |
| Metformin Hcl | Metformin Hcl | 173 | 58 |
| Ozempic | Semaglutide | 171 | 35 |
| Jardiance | Empagliflozin | 169 | 49 |
| Sertraline Hcl | Sertraline Hcl | 155 | 43 |
| Potassium Chloride | Potassium Chloride | 150 | 44 |
| Pravastatin Sodium | Pravastatin Sodium | 149 | 55 |
| Zolpidem Tartrate | Zolpidem Tartrate | 141 | 57 |
| Bupropion Xl | Bupropion Hcl | 127 | 41 |
| Tramadol Hcl | Tramadol Hcl | 125 | 42 |
| Allopurinol | Allopurinol | 120 | 46 |
| Simvastatin | Simvastatin | 114 | 43 |
| Valsartan | Valsartan | 114 | 36 |
| Ipratropium Bromide | Ipratropium Bromide | 113 | 30 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 99 | 33 |
| Chlorthalidone | Chlorthalidone | 92 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 91 | 28 |
| Synthroid | Levothyroxine Sodium | 90 | 23 |
| Spironolactone | Spironolactone | 89 | 30 |
| Furosemide | Furosemide | 88 | 39 |
| Repatha Sureclick | Evolocumab | 87 | 16 |
| Carvedilol | Carvedilol | 84 | 29 |
| Lorazepam | Lorazepam | 80 | 32 |
| Duloxetine Hcl | Duloxetine Hcl | 76 | 28 |
| Doxazosin Mesylate | Doxazosin Mesylate | 72 | 18 |
| Alprazolam | Alprazolam | 71 | 28 |
| Paroxetine Hcl | Paroxetine Hcl | 71 | 19 |
| Finasteride | Finasteride | 69 | 24 |
| Trulicity | Dulaglutide | 69 | 15 |
| Metoprolol Tartrate | Metoprolol Tartrate | 68 | 21 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 67 | 23 |
| Estradiol | Estradiol | 66 | 30 |
| Glimepiride | Glimepiride | 64 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 63 | 26 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 63 | 20 |
| Lovastatin | Lovastatin | 63 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 60 | 31 |
| Atenolol | Atenolol | 59 | 22 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 55 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 54 | 22 |
| Montelukast Sodium | Montelukast Sodium | 50 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 49 | 16 |
| Meloxicam | Meloxicam | 48 | 20 |
| Celecoxib | Celecoxib | 47 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 47 | 16 |
| Prednisone | Prednisone | 45 | 24 |
| Clonazepam | Clonazepam | 43 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 42 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 39 | 13 |
| Icosapent Ethyl | Icosapent Ethyl | 38 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 37 | 13 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 36 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 34 | suppressed |
| Mounjaro | Tirzepatide | 34 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 33 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 33 | suppressed |
| Xarelto | Rivaroxaban | 33 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 32 | suppressed |
| Irbesartan | Irbesartan | 32 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 31 | 17 |
| Famotidine | Famotidine | 31 | 12 |
| Naltrexone Hcl | Naltrexone Hcl | 31 | suppressed |
| Torsemide | Torsemide | 31 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 30 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 30 | suppressed |
| Ramipril | Ramipril | 30 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 28 | 11 |
| Acyclovir | Acyclovir | 27 | 13 |
| Nitroglycerin | Nitroglycerin | 27 | 13 |
| Testosterone Cypionate | Testosterone Cypionate | 27 | 12 |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Methocarbamol | Methocarbamol | 25 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | 13 |
| Digoxin | Digoxin | 24 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Glipizide Er | Glipizide | 24 | suppressed |
| Indapamide | Indapamide | 23 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 23 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 21 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 21 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 21 | suppressed |
| Nifedipine Er | Nifedipine | 21 | suppressed |
| Pregabalin | Pregabalin | 21 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 21 | suppressed |
| Vascepa | Icosapent Ethyl | 21 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 20 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 20 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 20 | suppressed |
| Ondansetron Odt | Ondansetron | 20 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 20 | suppressed |
| Testosterone | Testosterone | 20 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 19 | suppressed |
| Cephalexin | Cephalexin | 19 | 16 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Lansoprazole | Lansoprazole | 19 | suppressed |
| Memantine Hcl | Memantine Hcl | 19 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 19 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Levetiracetam | Levetiracetam | 17 | suppressed |
| Methylprednisolone | Methylprednisolone | 17 | 12 |
| Mirtazapine | Mirtazapine | 17 | suppressed |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 16 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 16 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Amiloride Hcl | Amiloride Hcl | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 13 | suppressed |
| Baclofen | Baclofen | 13 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 13 | suppressed |
| Eszopiclone | Eszopiclone | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 13 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 13 | 11 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Nexletol | Bempedoic Acid | 12 | suppressed |
| Pulmicort Flexhaler | Budesonide | 12 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Zaleplon | Zaleplon | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Glipizide | Glipizide | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Latanoprost | Latanoprost | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $346.83 · 3 records | Amgen Inc. | EVKEEZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error